β-Turned dipeptoids as potent and selective CCK1 receptor antagonists

Journal of Medicinal Chemistry

Volumn 43, Issue 20, 2000, Pages 3770-3777

  Martin Martinez, M ^a   De la Figuera, N ^a   Latorre, M ^b   Herranz, R ^a   Garcia Lopez, M T ^a   Cenarruzabeitia, E ^b   Del Rio, J ^b   Gonzalez Muniz, R ^a  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 (BENZYLOXYCARBONYL)AMINO 5 (1' BENZYL 2' CARBOXYETHYL)CARBAMOYL 3 OXO 2,3,5,6,11,11B HEXAHYDRO 1H INDOLIZINO[8,7 B]INDOLE; 2 (BENZYLOXYCARBONYL)AMINO 5 (1' CARBOXY 2' PHENYLETHYL)CARBAMOYL 3 OXO 2,3,5,6,11,11B HEXAHYDRO 1H INDOLIZINO[8,7 B]INDOLE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DIPEPTOID DERIVATIVE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; NONHUMAN; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CEREBRAL CORTEX; DIPEPTIDES; INDOLES; INDOLIZINES; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; PANCREAS; PROTEIN STRUCTURE, SECONDARY; RADIOLIGAND ASSAY; RATS; RECEPTORS, CHOLECYSTOKININ; STEREOISOMERISM;

EID: 0034609866     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000959x     Document Type: Article

References (47)

1. Biological actions of cholecystokinin
2. Cholecystokinin receptors
3. International union of pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors
4. Analysis of expression of cholecystokinin dopamine cells in the ventral mesenchephalon of several species and in humans with schizophrenia
5. Impaired cholecystokinin secretion in bulimia nervosa
6. Protective effect of CCK-8 and ceruletide on glutamate-induced neuronal cell death in rat neurone cultures: Possible involvement of CCK-B receptors
7. CCK-8S inhibits L-dopa-induced dyskinesias in Parkinsonian squirrel monkeys
8. Gastrointestinal Hormones and Gastrointestinal Cancer Growth
9. CCK in anxiety and cognitive processes
10. Association of enkephalin catabolism inhibitors and CCK-B antagonists: A potential use in the management of pain and opioid addiction
11. Cholecystokinin receptor antagonists: Current status
12. CCK antagonists: Pharmacological and therapeutic interest
13. Orally active nonpeptide CCK-A agonists
14. Update on nonpeptide CCK-B receptor antagonists
15. Recent advances in the chemistry of cholecystokinin ligands (Agonists and Antagonists)
16. Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors
17. α-Methyl tryptophanylphenylalanines and their arylethylamine dipeptoid analogues of the tetrapeptide cholecystokinin (30-33)
18. Rationally designed dipeptoid analogues of CCK. α-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties
19. Selective ligands for cholecystokinin receptor subtypes CCK-A and CCK-B within a single structural class
20. Cholecystokinin dipeptoid antagonists: Design, synthesis, and anxiolytic profile of some Novel CCK-A and CCK-B selective and mixed CCK-A/CCK-B antagonists
21. Rational designed dieptoid analogues of cholecystokinin (CCK): C-Terminal structure-activity relationships of α-Methyl tryptophan derivatives
22. Synthesis and SAR studies of novel CCK-B antagonists
23. Cholecystokinin peptidomimetics as selective CCK-B antagonists: Design, synthesis and in vitro and in vivo biochemical properties
24. Second generation peptoid CCK-B receptor antagonists: Identification and development of N-(adamantyloxycarbonyl)-α-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile
25. The use of a proline ring as a conformational restraint in cck-b receptor dipeptoids
26. The use of heterocycles for the conformational restriction of biologically active peptoids
27. Synthesis and CCK-B binding affinities of cyclic analogues of the potent and selective CCK-B receptor antagonist CI-988
28. Synthesis of conformationally constrained macrocyclic analogues of the potent and selective CCK-B antagonist CI-988
29. Amide bond replacements incorporated into CCK-B selective dipeptoids
30. Synthesis and biological properties of new constrained CCK-B antagonists: Discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
31. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid
32. Conformationally restricted analogues of the potent CCK-B antagonist CI-988
33. Diastereoselective synthesis of cyclopropyl phenylalanines and their incorporation into dipeptides
34. Preparation of dipeptoid mimetics for the tetrapeptide cholecystokinin, CCK-(30-33)
35. α,β-Didehydrotryptophan as surrogate for α-methyltryptophan in CCK peptoids related to CI-988
36. Linear oligopeptides. 252. α,β-dehydro-amino acid residues in the design of peptide structures. Molecular crystal stuctures of two folded dehydro peptides
37. Conformational properties of peptides containing dehydro amino acids
38. Highly constrained dipeptoid analogues containing a type II' β-turn mimic as novel and selective CCK-A receptor ligands
39. 2-Amino-3-oxohexahydroindolizino [8,7-b]-indole-5-carboxylate derivatives as new scaffolds for mimicking β-turn secondary structures.Molecular dynamics and stereoselective synthesis
40. IBTM-containing gramicidin S analogues: Evidence for IBTM as a suitable type II' β-turn mimetic
41. Diastereo- and enantioselectivity in the pictet - Spengler reaction
42. Conformation and biological activity of cyclic peptides
43. Pharmacological evaluation of IQM-95,333 a highly selective CCK-A receptor antagonist with anxiolytic-like activity in animal models
44. Biochemical and pharmacological characterization of a new and extremely potent and selective nonpeptide cholecystokinin antagonist
45. Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas
46. Synthesis of a potent and selective non-peptide CCK-B/gastrin receptor antagonist tritiated ligand
47. Kinetics of amylase release by dispersed acini prepared from guinea pig pancreas